236 related articles for article (PubMed ID: 29709423)
1. Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder.
Yamada S; Ito Y; Nishijima S; Kadekawa K; Sugaya K
Pharmacol Ther; 2018 Sep; 189():130-148. PubMed ID: 29709423
[TBL] [Abstract][Full Text] [Related]
2. Predicting muscarinic receptor occupancy in human bladder mucosa from urinary concentrations of antimuscarinic agents for overactive bladder.
Shiho M; Akashita G; Nakatani E; Tanaka S; Yamada S; Okura T
Drug Metab Pharmacokinet; 2024 Jun; 56():100998. PubMed ID: 38583388
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety, efficacy, and tolerability of imidafenacin in the treatment of overactive bladder: a review of the Japanese literature.
Masumori N
Patient Prefer Adherence; 2013; 7():111-20. PubMed ID: 23390360
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.
Araklitis G; Robinson D; Cardozo L
Clin Interv Aging; 2020; 15():1493-1503. PubMed ID: 32921995
[TBL] [Abstract][Full Text] [Related]
5. What is the best first choice oral drug therapy for OAB?
Sahai A; Robinson D; Abrams P; Wein A; Malde S
Neurourol Urodyn; 2024 Aug; 43(6):1328-1336. PubMed ID: 38270332
[TBL] [Abstract][Full Text] [Related]
6. Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions.
Milsom I; Wagg A; Oelke M; Chapple C
Int J Clin Pract; 2021 Apr; 75(4):e13870. PubMed ID: 33251651
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review.
Vozmediano-Chicharro R; Blasco Hernández P; Madurga-Patuel B
Res Rep Urol; 2020; 12():321-330. PubMed ID: 32884926
[TBL] [Abstract][Full Text] [Related]
8. An update on the use of transdermal oxybutynin in the management of overactive bladder disorder.
Cohn JA; Brown ET; Reynolds WS; Kaufman MR; Milam DF; Dmochowski RR
Ther Adv Urol; 2016 Apr; 8(2):83-90. PubMed ID: 27034721
[TBL] [Abstract][Full Text] [Related]
9. Update on tolterodine extended-release for treatment of overactive bladder.
Omotosho T; Chen CC
Open Access J Urol; 2010 Nov; 2():185-91. PubMed ID: 24198627
[TBL] [Abstract][Full Text] [Related]
10. The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review.
Welk B
Indian J Urol; 2024; 40(2):82-87. PubMed ID: 38725892
[TBL] [Abstract][Full Text] [Related]
11. A prospective, comparative study of the occurrence and severity of constipation with darifenacin and trospium in overactive bladder.
Manjunatha R; Pundarikaksha HP; Hanumantharaju BK; Anusha SJ
J Clin Diagn Res; 2015 Mar; 9(3):FC05-9. PubMed ID: 25954630
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment.
Gandi C; Sacco E
Clin Pharmacol; 2021; 13():209-223. PubMed ID: 34858068
[TBL] [Abstract][Full Text] [Related]
13. Prospective pharmacologic therapies for the overactive bladder.
Andersson KE
Ther Adv Urol; 2009 Jun; 1(2):71-83. PubMed ID: 21789056
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the treatment of overactive bladder in the elderly.
Macdiarmid SA
Rev Urol; 2008; 10(1):6-13. PubMed ID: 18470275
[TBL] [Abstract][Full Text] [Related]
15. Is behavioral therapy plus antimuscarinic better than drug alone to treat overactive bladder?
Chancellor MB; Hasenau DL
Rev Urol; 2008; 10(4):306-8. PubMed ID: 19145277
[No Abstract] [Full Text] [Related]
16. The concern about noradrenergic and antimuscarinic agents for OSA.
Wang D; Chen R; Zhang N
Sleep Biol Rhythms; 2022 Apr; 20(2):319-320. PubMed ID: 38469266
[No Abstract] [Full Text] [Related]
17. Managing overactive bladder.
Robinson D; Cardozo L
Climacteric; 2019 Jun; 22(3):250-256. PubMed ID: 31034265
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
Yamaguchi O; Kakizaki H; Homma Y; Igawa Y; Takeda M; Nishizawa O; Gotoh M; Yoshida M; Yokoyama O; Seki N; Okitsu A; Hamada T; Kobayashi A; Kuroishi K
Int J Urol; 2019 Mar; 26(3):342-352. PubMed ID: 30548692
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
